NFKB1 and type 2 diabetes mellitus: Metformin administration ameliorates the inflammatory response associated with diabetic nephropathy in type 2 diabetic mice by reducing the increases in NF-κB and serum levels of proinflammatory cytokines (IL-1β and TNF-α) [87].